In this day and age of connected living, almost everything imaginable is being adopted into an online activity. One such area transitioning rapidly online is healthcare. The field of digital therapeutics is observing a boost since COVID-19, both, in terms of adoption and investments. The Nordic digital therapeutics company SidekickHealth has established itself as a successful startup and now it has announced securing a multi-million dollar deal partnership with the pharmaceutical giant Pfizer.
SidekickHealth: Empowering patients to take control
Details of the deal between Pfizer and SidekickHealth are yet to be disclosed. However, a source close to the development suggested Silicon Canals that it is somewhere around €7 to €8 million ($8-9 million). This collaboration between the two companies is aimed at empowering patients to take control of their health and focuses on a number of therapeutic areas.